Genetron Holdings

General Information


We are a leading and fast-growing precision oncology company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. We have developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.

Employees: 697
Founded: 2015
Contact Information
Address 1-2/F, Building 11, Zone 1, No.8 Life Science Parkway Changping District, Beijing, People’s Republic of China
Phone Number +86 10 5090-7500
Web Address
View Prospectus: Genetron Holdings
Financial Information
Market Cap $1104.5mil
Revenues $47.1 mil (last 12 months)
Net Income $-92.7 mil (last 12 months)
IPO Profile
Symbol GTH
Exchange NASDAQ
Shares (millions): 16.0
Price range $16.00 - $16.00
Est. $ Volume $256.0 mil
Manager / Joint Managers Credit Suisse/ CICC
CO-Managers BTIG/ Canaccord Genuity
Expected To Trade: 6/19/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change